CA2074318A1 - Prosthetic implant with self-generated current for early fixation in skeletal bone - Google Patents
Prosthetic implant with self-generated current for early fixation in skeletal boneInfo
- Publication number
- CA2074318A1 CA2074318A1 CA002074318A CA2074318A CA2074318A1 CA 2074318 A1 CA2074318 A1 CA 2074318A1 CA 002074318 A CA002074318 A CA 002074318A CA 2074318 A CA2074318 A CA 2074318A CA 2074318 A1 CA2074318 A1 CA 2074318A1
- Authority
- CA
- Canada
- Prior art keywords
- prosthetic implant
- porous
- implant according
- bone
- anode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/06—Titanium or titanium alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/205—Applying electric currents by contact electrodes continuous direct currents for promoting a biological process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30721—Accessories
- A61F2/30749—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2821—Bone stimulation by electromagnetic fields or electric current for enhancing ossification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30224—Three-dimensional shapes cylindrical
- A61F2002/30235—Three-dimensional shapes cylindrical tubular, e.g. sleeves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30772—Apertures or holes, e.g. of circular cross section
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30968—Sintering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Cardiology (AREA)
- Dentistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Abstract A prosthetic implant for implantation into skeletal bone comprising an implantable base member having an internal housing surrounded partially by a porous wall, an anode secured in the internal housing and in electrical contact with the porous wall, and a porous means placed in the internal housing for retaining a biocompatible electrolyte. When implanted into bone structure, the prosthetic implant generates sufficient current flow which results in invivo formation of calcium phosphate minerals between the implant and the surrounding bone, thereby, resulting in im-proved fixation and stability of the implant.
Description
Background of the Invention Field of the Invention:
The invention relates to medical prostheses for implantation in a body, and more particularly, to prostheses which are intended to be fixed into the skeletal structures, such as dental implants and hip joint prostheses.
Description of the Prior_Art:
Medical implants such as dental implants and joint prostheses are normally implanted into the skeletal structure of humàns to replace missing or damaged skeletal parts. Often, it is intended that these implants become a permanent part of the skeletal structure.
It is important, therefore, that the metal implant be strongly fixed to the skeletal bone structure. Traditional problems, in implant placement and post-operative instability, have been associated with inability to create a precision site, bone die-back associated with the trauma of high-speed burning or over-zealous removal of bone in site preparation, inability of the patient's body to build new bone quickly (as a result of, for example, metabolic bone diseases), physiological barrier to exact implant placement and errors.
Attempts to address these problems have included the use of ;~
bone cement for total hip replacement. See, for example, J. Charnley, et al, "The long term reaction of bone to self-curing acrylic cement", J. Bone Joint Sura., 503, 822-829 (1968). In cemented arthroplasties, the cement provides initial rigid fixation and stability. However, immediate loading does not allow the prepared site the time to recover from trauma. Furthermore, cement has the complicating factor of additional chance for thermally induced necrosis as curing exotherm heat is released. A fibrous tissue layer is also commonly observed at the interface between bone and acrylic cement. Ideally, however, total bony interfaces are most desirable since a device so fixed would be able to transfer loads efficiently.
In recent years, the search for better mechanisms to increase initial stability and to minimize the occurrence of gradual loosening of prostheses has le* to the development of cementless prostheses.
.: ~ . . . ,; .
.. .. .
,,'' ' '' ,',' ' ~; ~
.
The development of cementless prostheses, however, has le~ to an entirely new set of problems regarding initial stability. Cement-less prostheses, must achieve their initial stability by obtaining an exact surgical press fit. Although a large number of prosthesis sizes are available, there will be areas of good contact and other areas of poor contact or gaps between the implant and the bone. This problem may be even greater in patients with osteopenic bone and at cementless revision of failed arthroplasties, which may have large bone defects.
The cementless fixation of porous-coated implants, by bony ingrowth,-is also widely used, but this technique is not without associated problems. Recent investigations have shown that for bone to grow into the porous-coated implants, there must be a relatively good mating of the contact surfaces and some form of stabilization and/or patient immobilization during the initial growth phase as to prevent gross movements of the implant. Attempts have been made in the past to shorten the time required for initial implant stabilization by coating porous surfaces with calcium phosphate ceramics. However, such coatings are mechanically unstable and may dissolve under physiological conditions and, thus, the implant may become loose over a ~ong time period. On the other hand, a good mating between implant and bone is still required in order to achieve desirable fixation.
Summary of the Invention It is an object of the invention to provide a prosthesis that results in rapid invivo formation of calcium phosphate minerals at the implant-bone interface and also encourages bone attachment to the implant when~implanted in the body, thereby, providing early and strong fixation of the implant into the skeletal structure.
An~ther object of the invention is to provide a prosthesis with internal electrochemical facilities which results in sufficient flow of electrical current when implanted in the body, thereby, resuiting in electrical stimul~tion of osteogenesis in close proximity of the implant A further object of the invention is to provide a prosthesis and a method of fixation of prostheses in bone, which overcome the , . : , ... ,. . ~. , , , : . . ~ - ::.: ....
::. ,: , : ., , , :: ;, : -;. . . .
: ,.. .
.
disadvantages of the prior art prostheses that were intended to be permanent~y affixed to bone.
The invention provides a prosthetic implant for use as a body implant and for stimulating bone formation in close proximity of said implant comprising: an implantable base member having an internal housing surrounded at least partially by a~conductive porous wall, said porous wall having an outer surface on which bone attachment is desired, an inner surface and a plurality of apertures extending from said inner surface through said wall to said outer surface, and adopted for tissue ingrowth when prosthetic implant is implanted in the body; a prous means located in said internal housing retaining a biocompatible electrolyte,said electrolyte being in contact with said inner surface of said porous wall; an anode also secured within said internal housing, said anode being in contact with said electrol~te; and means for electrically connecting said anode to said porous wall so as to form a galvanic couple and to generate sufficient current flow to induce invivo precipitation of c~,;cium phosphate minerals on said outer surface of said porous wall and to stimulate bone growth into said porous wall.
Deæcription of the Preferred Embodiment A more complete appreciation of the invention will bè readily apparent by reference to the accompanying drawing, wherein:
Fig. 1 is a cross-sectional view of a prosthétic implant according to one embodiment of the invention; and Fig. 2 is a cross-sectional view of the implantable base member of the prosthetic implant shown in Fig. 1.
Referring to Fig. 1, there is shown a prosthetic implant in~ended to be permanently fixed into bone. The particular implant shown is a dental root implant, having a cylindrical shape. The prosthetic implant ~omprlseæ an implantable base member 1, which may be made of a biocompatible material such as titanium or titanium-based alloys.
As shown in Fig. 2, base member 1 is provided with an internal housing 3, which is partially surrounded by a porous wall 5. The porous wall 5 has an inner surface, an outer surface and plurality , .. , : , ;.
:. ~ . ..
.
of apertures 7, extending from said inner surface through said wall to said outer surface. The outer surface of the porous wall 5 is intended to form a strong bond with bone and the apertures 7 are adopted to facilitate body fluid ingress and tissue ingrowth when prosthetic implant is implanted in the body. In the preferred embodiment, the apertures 7 are provided in a uniformly spaced manner. Also, in the preferred embodiment, there are at least 20 of the apertures 7 of a generally circular cross-section and having interior diameters in the range of 50 to 300 microns. It is contemplated, however, that the diameters of the apertures could be varied or that the apertures could be formed in different geometrical shapes. The thickness of the porou~ wall 5 is determined by the stability from the standpoint of forming the porous wall. Roughly, however, the thickness of the porous wall ranges from 1 to 3 mm.
In order to enhance the fixation of the prosthetic implant in bone, the outer surface of the porous wall 5 may have its microsurface area increased by roughening to form at least one area with crevices, irr~g~larities, protuberances, etc., thereon. It should be under-stood, however, that any of the various types of porous surfaces used for fixation of parts implanted in the body may also be !, incorporated in the invention. For example, common porous coatings which may be incorporated in the present invention, are sintered coatings of metal particles and fibres.
As shown in Fig. 1, the prosthetic implant in this invention further comprises an anode 9 secured in the internal housing 3 and is electrically in contact with the porous wall 5. The prosthetic implant of this invention further comprises a porous means 11, placed inside the internal housing 3 for retaining a biocompatible electrolyte. The electrolyte preferably contains at least Ca-and P- bearing ions and has a pH in the range of 3 to 7. Suitable anode materials for use in this invention are alloys containing Calcium, Magnesium or a combination of theæe. It is also possible to use metal hydrides as the anode material. Many metals and inter metallic compounds form hydride readily because of their high affinity for hydrogen and may be used in this invention. For example, -, : .
; ~ . . . :: . : .
: : -: :.... : :
hydrogen storage alloys such as LaNis can absorb a large amount of hydrogen and form a metal hydride which can be represented by the chemical formula LaNisH6. Other metal hydrides which can be used are, for example, titanium hydride, magnesium hydride and FeTiH2.
In order to enhance the surface activity of the metal hydrides, used in this invention, it is desirable to provide a protective coating for these materials. Coatings of Palladium and Pd-Ag alloys are, in particular, beneficial for this purpose.
The porous means 11 may be made of synthetic fibers, plastics, metals, or ceramics and preferably have a porosity of about 25 percent or more, so as to permit said electrolyte to permeate through and contact both anode 9 and porous wall 5. It is particularly desirable to employ physiologically-acceptable porous ceramics for -^
this purpose. For example, porous ceramics, composed of a salt having a cation selected from the group consisting of physiologically acceptable alkali metals, alkaline earth metals and an anion selected from the group consisting of phosphate, carbonate, and silicate, may be used for this purpose. In particular, it is desirable to use a sintered p4rous mass of calcium phosphate ceramic for this purpose. The calcium phosphate may be selected from the group consisting of tricalcium phosphate (TCP), hydroxyapatite (HA), carbonate-containing apatite, fluro-apatite and mixtures thereof.
The porous means 11 may additionally contain biologically active substances such as bone morphogenic protein (BMP), collagen and antibiotics. For example, porous means 11 may be substantially pure BMP in combination with a biodegradable porous sintered beta-tricalcium phosphate, and may be prepared by admixing the ~MP with the porous ceramic material.
The electrolyte may be introduced into the porous means 11 by, for example, dipping the prosthetic implant in a biocompatible solution,~ha~ing a pH in the range of 3 to 5. It is desirable to introduce the electrolyte into the porous means 11 shortly before the prosthetic implant is implanted in the body. Alternatively, the prosthetic implant of this invention may be implanted in the body without incorporating the electrolyte. In this case, once the , . .: ' .:
. , i .
prosthetic implant is implanted, the body fluid in close proximity to the prosthetic implant enters the implant via apertures 7 and permeates through the porous~ means 11 in a relatively short period of time. The body fluid contains Ca- and P- bearing ions and has sufficient conductivity and acts as an electrolyte.
Once the electrolyte permeates through the porous means 11 an comes in contact with both anode 9 and the porous wall 5, a galvanic cell is formed in which the porous wall 5 acts as the cathode of the galvanic cell. An important reaction, taking place invivo on the porous wall 5, is the electrochemical reduction of dissolved oxygen in body fluid. As a result of this reaction, the pH, in close proximity of the porous wall 5, increases to the extent that calcium phosphate minerals precipitate on the outer surface of porous wall 5. Ca- and P- bearing ions required for invivo form-ation of calcium phosphate minerals are supplied by the body fluid and also originates from the interior of the prosthetic implant. The calcium phosphate minerals, formed invivo on the outer surface of the porous wall 5, eventually fill the gaps between the implant surface and the surrounding bone and results in improved implant stability, in a relatively short period of time.
The galvanic cell, formed within the prosthetic implant, further generates a small galvanic current which has beneficial stimulating effect on bone growth in close proximity of the pros-thetic implant. The magnitude of the galvanic current, generated invivo, prima~ily~depends on the electrochemical activity and the surface area of the anode 9. It is desirable to select anodes with sufficient electrochemical activity and surface area which result in a galvanic current flow of about 20 microamperes per square centimeter of the porous wall 5. It has been known for some time that provision of a small direct current flowing to a cathode near bone will stimulate bone growth at the bone-cathode interface.
The present invention, therefore, provides a prosthetic implant which electrochemically stimulates bone growth in close proximity of the implant without the need for an external power supply.
- : . - : ..
.. . . . . .. . .. ..
- :: : ~
:: . .. : ... :: . -- : . .
:, :, . , . :, ~
- : . ,, ,:
: -:: . .: . . . ~ . :
- :. . :
A novel prosthetic implant, for implantation in the skeletal bone and the method for making the implant which results in im-proved fixation and stability of the implant, has been described.
While the above description of the invention has been referenced to one particular implant, it is evident that the inventive concepts described, herein, can be applied to improve stability of many types of implantable devices such as knee prostheses, intramedullary rods, hip prootheses, etc. For example, the inventive concepts of the present invention may be employed to improve stability of the femural component of a hip prosthesis in the skeletal bone by providing an internal housing in the proximal section of the stem.
The internal housing is surrounded, partially, by a porous wall and is used to accomodate an anode and a porous means for retaining a biocompatible electrolyte so asito form a galvanic couple~as described above.and according to the principles of this invention.
It is clear that now that the principles of the invention have been disclosed, those skilled in the art, can apply these principles to improve the stability and fixation of other implantable components.
Consequently, the invention is ~o be construed as embracing each and every novel feature and novel combination of features within the appended claims.
' ' , ~,.
,
The invention relates to medical prostheses for implantation in a body, and more particularly, to prostheses which are intended to be fixed into the skeletal structures, such as dental implants and hip joint prostheses.
Description of the Prior_Art:
Medical implants such as dental implants and joint prostheses are normally implanted into the skeletal structure of humàns to replace missing or damaged skeletal parts. Often, it is intended that these implants become a permanent part of the skeletal structure.
It is important, therefore, that the metal implant be strongly fixed to the skeletal bone structure. Traditional problems, in implant placement and post-operative instability, have been associated with inability to create a precision site, bone die-back associated with the trauma of high-speed burning or over-zealous removal of bone in site preparation, inability of the patient's body to build new bone quickly (as a result of, for example, metabolic bone diseases), physiological barrier to exact implant placement and errors.
Attempts to address these problems have included the use of ;~
bone cement for total hip replacement. See, for example, J. Charnley, et al, "The long term reaction of bone to self-curing acrylic cement", J. Bone Joint Sura., 503, 822-829 (1968). In cemented arthroplasties, the cement provides initial rigid fixation and stability. However, immediate loading does not allow the prepared site the time to recover from trauma. Furthermore, cement has the complicating factor of additional chance for thermally induced necrosis as curing exotherm heat is released. A fibrous tissue layer is also commonly observed at the interface between bone and acrylic cement. Ideally, however, total bony interfaces are most desirable since a device so fixed would be able to transfer loads efficiently.
In recent years, the search for better mechanisms to increase initial stability and to minimize the occurrence of gradual loosening of prostheses has le* to the development of cementless prostheses.
.: ~ . . . ,; .
.. .. .
,,'' ' '' ,',' ' ~; ~
.
The development of cementless prostheses, however, has le~ to an entirely new set of problems regarding initial stability. Cement-less prostheses, must achieve their initial stability by obtaining an exact surgical press fit. Although a large number of prosthesis sizes are available, there will be areas of good contact and other areas of poor contact or gaps between the implant and the bone. This problem may be even greater in patients with osteopenic bone and at cementless revision of failed arthroplasties, which may have large bone defects.
The cementless fixation of porous-coated implants, by bony ingrowth,-is also widely used, but this technique is not without associated problems. Recent investigations have shown that for bone to grow into the porous-coated implants, there must be a relatively good mating of the contact surfaces and some form of stabilization and/or patient immobilization during the initial growth phase as to prevent gross movements of the implant. Attempts have been made in the past to shorten the time required for initial implant stabilization by coating porous surfaces with calcium phosphate ceramics. However, such coatings are mechanically unstable and may dissolve under physiological conditions and, thus, the implant may become loose over a ~ong time period. On the other hand, a good mating between implant and bone is still required in order to achieve desirable fixation.
Summary of the Invention It is an object of the invention to provide a prosthesis that results in rapid invivo formation of calcium phosphate minerals at the implant-bone interface and also encourages bone attachment to the implant when~implanted in the body, thereby, providing early and strong fixation of the implant into the skeletal structure.
An~ther object of the invention is to provide a prosthesis with internal electrochemical facilities which results in sufficient flow of electrical current when implanted in the body, thereby, resuiting in electrical stimul~tion of osteogenesis in close proximity of the implant A further object of the invention is to provide a prosthesis and a method of fixation of prostheses in bone, which overcome the , . : , ... ,. . ~. , , , : . . ~ - ::.: ....
::. ,: , : ., , , :: ;, : -;. . . .
: ,.. .
.
disadvantages of the prior art prostheses that were intended to be permanent~y affixed to bone.
The invention provides a prosthetic implant for use as a body implant and for stimulating bone formation in close proximity of said implant comprising: an implantable base member having an internal housing surrounded at least partially by a~conductive porous wall, said porous wall having an outer surface on which bone attachment is desired, an inner surface and a plurality of apertures extending from said inner surface through said wall to said outer surface, and adopted for tissue ingrowth when prosthetic implant is implanted in the body; a prous means located in said internal housing retaining a biocompatible electrolyte,said electrolyte being in contact with said inner surface of said porous wall; an anode also secured within said internal housing, said anode being in contact with said electrol~te; and means for electrically connecting said anode to said porous wall so as to form a galvanic couple and to generate sufficient current flow to induce invivo precipitation of c~,;cium phosphate minerals on said outer surface of said porous wall and to stimulate bone growth into said porous wall.
Deæcription of the Preferred Embodiment A more complete appreciation of the invention will bè readily apparent by reference to the accompanying drawing, wherein:
Fig. 1 is a cross-sectional view of a prosthétic implant according to one embodiment of the invention; and Fig. 2 is a cross-sectional view of the implantable base member of the prosthetic implant shown in Fig. 1.
Referring to Fig. 1, there is shown a prosthetic implant in~ended to be permanently fixed into bone. The particular implant shown is a dental root implant, having a cylindrical shape. The prosthetic implant ~omprlseæ an implantable base member 1, which may be made of a biocompatible material such as titanium or titanium-based alloys.
As shown in Fig. 2, base member 1 is provided with an internal housing 3, which is partially surrounded by a porous wall 5. The porous wall 5 has an inner surface, an outer surface and plurality , .. , : , ;.
:. ~ . ..
.
of apertures 7, extending from said inner surface through said wall to said outer surface. The outer surface of the porous wall 5 is intended to form a strong bond with bone and the apertures 7 are adopted to facilitate body fluid ingress and tissue ingrowth when prosthetic implant is implanted in the body. In the preferred embodiment, the apertures 7 are provided in a uniformly spaced manner. Also, in the preferred embodiment, there are at least 20 of the apertures 7 of a generally circular cross-section and having interior diameters in the range of 50 to 300 microns. It is contemplated, however, that the diameters of the apertures could be varied or that the apertures could be formed in different geometrical shapes. The thickness of the porou~ wall 5 is determined by the stability from the standpoint of forming the porous wall. Roughly, however, the thickness of the porous wall ranges from 1 to 3 mm.
In order to enhance the fixation of the prosthetic implant in bone, the outer surface of the porous wall 5 may have its microsurface area increased by roughening to form at least one area with crevices, irr~g~larities, protuberances, etc., thereon. It should be under-stood, however, that any of the various types of porous surfaces used for fixation of parts implanted in the body may also be !, incorporated in the invention. For example, common porous coatings which may be incorporated in the present invention, are sintered coatings of metal particles and fibres.
As shown in Fig. 1, the prosthetic implant in this invention further comprises an anode 9 secured in the internal housing 3 and is electrically in contact with the porous wall 5. The prosthetic implant of this invention further comprises a porous means 11, placed inside the internal housing 3 for retaining a biocompatible electrolyte. The electrolyte preferably contains at least Ca-and P- bearing ions and has a pH in the range of 3 to 7. Suitable anode materials for use in this invention are alloys containing Calcium, Magnesium or a combination of theæe. It is also possible to use metal hydrides as the anode material. Many metals and inter metallic compounds form hydride readily because of their high affinity for hydrogen and may be used in this invention. For example, -, : .
; ~ . . . :: . : .
: : -: :.... : :
hydrogen storage alloys such as LaNis can absorb a large amount of hydrogen and form a metal hydride which can be represented by the chemical formula LaNisH6. Other metal hydrides which can be used are, for example, titanium hydride, magnesium hydride and FeTiH2.
In order to enhance the surface activity of the metal hydrides, used in this invention, it is desirable to provide a protective coating for these materials. Coatings of Palladium and Pd-Ag alloys are, in particular, beneficial for this purpose.
The porous means 11 may be made of synthetic fibers, plastics, metals, or ceramics and preferably have a porosity of about 25 percent or more, so as to permit said electrolyte to permeate through and contact both anode 9 and porous wall 5. It is particularly desirable to employ physiologically-acceptable porous ceramics for -^
this purpose. For example, porous ceramics, composed of a salt having a cation selected from the group consisting of physiologically acceptable alkali metals, alkaline earth metals and an anion selected from the group consisting of phosphate, carbonate, and silicate, may be used for this purpose. In particular, it is desirable to use a sintered p4rous mass of calcium phosphate ceramic for this purpose. The calcium phosphate may be selected from the group consisting of tricalcium phosphate (TCP), hydroxyapatite (HA), carbonate-containing apatite, fluro-apatite and mixtures thereof.
The porous means 11 may additionally contain biologically active substances such as bone morphogenic protein (BMP), collagen and antibiotics. For example, porous means 11 may be substantially pure BMP in combination with a biodegradable porous sintered beta-tricalcium phosphate, and may be prepared by admixing the ~MP with the porous ceramic material.
The electrolyte may be introduced into the porous means 11 by, for example, dipping the prosthetic implant in a biocompatible solution,~ha~ing a pH in the range of 3 to 5. It is desirable to introduce the electrolyte into the porous means 11 shortly before the prosthetic implant is implanted in the body. Alternatively, the prosthetic implant of this invention may be implanted in the body without incorporating the electrolyte. In this case, once the , . .: ' .:
. , i .
prosthetic implant is implanted, the body fluid in close proximity to the prosthetic implant enters the implant via apertures 7 and permeates through the porous~ means 11 in a relatively short period of time. The body fluid contains Ca- and P- bearing ions and has sufficient conductivity and acts as an electrolyte.
Once the electrolyte permeates through the porous means 11 an comes in contact with both anode 9 and the porous wall 5, a galvanic cell is formed in which the porous wall 5 acts as the cathode of the galvanic cell. An important reaction, taking place invivo on the porous wall 5, is the electrochemical reduction of dissolved oxygen in body fluid. As a result of this reaction, the pH, in close proximity of the porous wall 5, increases to the extent that calcium phosphate minerals precipitate on the outer surface of porous wall 5. Ca- and P- bearing ions required for invivo form-ation of calcium phosphate minerals are supplied by the body fluid and also originates from the interior of the prosthetic implant. The calcium phosphate minerals, formed invivo on the outer surface of the porous wall 5, eventually fill the gaps between the implant surface and the surrounding bone and results in improved implant stability, in a relatively short period of time.
The galvanic cell, formed within the prosthetic implant, further generates a small galvanic current which has beneficial stimulating effect on bone growth in close proximity of the pros-thetic implant. The magnitude of the galvanic current, generated invivo, prima~ily~depends on the electrochemical activity and the surface area of the anode 9. It is desirable to select anodes with sufficient electrochemical activity and surface area which result in a galvanic current flow of about 20 microamperes per square centimeter of the porous wall 5. It has been known for some time that provision of a small direct current flowing to a cathode near bone will stimulate bone growth at the bone-cathode interface.
The present invention, therefore, provides a prosthetic implant which electrochemically stimulates bone growth in close proximity of the implant without the need for an external power supply.
- : . - : ..
.. . . . . .. . .. ..
- :: : ~
:: . .. : ... :: . -- : . .
:, :, . , . :, ~
- : . ,, ,:
: -:: . .: . . . ~ . :
- :. . :
A novel prosthetic implant, for implantation in the skeletal bone and the method for making the implant which results in im-proved fixation and stability of the implant, has been described.
While the above description of the invention has been referenced to one particular implant, it is evident that the inventive concepts described, herein, can be applied to improve stability of many types of implantable devices such as knee prostheses, intramedullary rods, hip prootheses, etc. For example, the inventive concepts of the present invention may be employed to improve stability of the femural component of a hip prosthesis in the skeletal bone by providing an internal housing in the proximal section of the stem.
The internal housing is surrounded, partially, by a porous wall and is used to accomodate an anode and a porous means for retaining a biocompatible electrolyte so asito form a galvanic couple~as described above.and according to the principles of this invention.
It is clear that now that the principles of the invention have been disclosed, those skilled in the art, can apply these principles to improve the stability and fixation of other implantable components.
Consequently, the invention is ~o be construed as embracing each and every novel feature and novel combination of features within the appended claims.
' ' , ~,.
,
Claims (15)
1. A prosthetic implant for use as a body implant and for stimulating bone formation in close proximity of said implant comprising:
An implantable base member having an internal housing surrounded at least partially by a conductive porous wall, said porous wall having an outer surface on which bone attachment is desired, an inner surface and a plurality of apertures extending from said inner surface through said wall to said outer surface, and adopted for tissue ingrowth when prosthetic implant is implanted in the body; a porous means located in said internal housing retaining a biocompatible electrolyte, said electrolyte being in contact with said inner surface of said porous wall; an anode also secured within said internal housing, said anode being in contact with said electrolyte and means for electrically connecting said anode to said porous wall so as to form a galvanic couple and to generate sufficient current flow to induce precipitation of calcium phosphate minerals on said outer surface of said porous wall and to stimulate bone growth into said porous wall.
An implantable base member having an internal housing surrounded at least partially by a conductive porous wall, said porous wall having an outer surface on which bone attachment is desired, an inner surface and a plurality of apertures extending from said inner surface through said wall to said outer surface, and adopted for tissue ingrowth when prosthetic implant is implanted in the body; a porous means located in said internal housing retaining a biocompatible electrolyte, said electrolyte being in contact with said inner surface of said porous wall; an anode also secured within said internal housing, said anode being in contact with said electrolyte and means for electrically connecting said anode to said porous wall so as to form a galvanic couple and to generate sufficient current flow to induce precipitation of calcium phosphate minerals on said outer surface of said porous wall and to stimulate bone growth into said porous wall.
2. A prosthetic implant according to claim 1 wherein said implantable member is formed of titanium or titanium-based alloys.
3. A prosthetic implant according to claim 1 wherein the outer surface of said porous wall has at least one roughened area to enhance fixation of the implant in skeletal bone.
4. A prosthetic implant according to claim 1 wherein said apertures have diameters less than 5 mm.
5. A prosthetic implant according to claim 1 wherein said anode is porous.
6. A prosthetic implant according to claim 1 wherein said anode con-tains calcium and/or magnesium.
7. A prosthetic implant according to claim 1 wherein said anode is made of a metal hydride charged with hydrogen.
8. A prosthetic implant according to claim 1 wherein said porous means is made of ceramics.
9. A prosthetic implant according to claim 1 wherein said porous means is made of a biocompatible calcium phosphate ceramic of the apatite group.
10. A prosthetic implant according to claim 1 wherein said porous means is made of tricalcium phosphate (TCP).
11. A prosthetic implant according to claim 1 wherein said porous means is made of a conductive material selected from the group consisting of calcium and/or magnesium containing alloys and metal hydrides charged with hydrogen.
12. A prosthetic implant according to claim 1 wherein said porous means contains biologically active substances selected from the group consisting of bone morphogenic protein (BMP), collagen and antibiotics.
13. A prosthetic implant according to claim 1 wherein said bio-compatible electrolyte contains Ca- and P- bearing ions and a pH ranging from about 3 to 8.
14. A prosthetic implant according to claim 1 wherein said implantable base member is a dental root implant.
15. A prosthetic implant according to claim 1 wherein said implantable base member is the femural component of a hip prosthesis.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002074318A CA2074318A1 (en) | 1992-07-22 | 1992-07-22 | Prosthetic implant with self-generated current for early fixation in skeletal bone |
US08/127,491 US5383935A (en) | 1992-07-22 | 1993-09-28 | Prosthetic implant with self-generated current for early fixation in skeletal bone |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002074318A CA2074318A1 (en) | 1992-07-22 | 1992-07-22 | Prosthetic implant with self-generated current for early fixation in skeletal bone |
US08/127,491 US5383935A (en) | 1992-07-22 | 1993-09-28 | Prosthetic implant with self-generated current for early fixation in skeletal bone |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2074318A1 true CA2074318A1 (en) | 1994-01-23 |
Family
ID=25675351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002074318A Abandoned CA2074318A1 (en) | 1992-07-22 | 1992-07-22 | Prosthetic implant with self-generated current for early fixation in skeletal bone |
Country Status (2)
Country | Link |
---|---|
US (1) | US5383935A (en) |
CA (1) | CA2074318A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112040893A (en) * | 2018-04-10 | 2020-12-04 | 德普伊新特斯产品公司 | Bipolar bone anchor with connector for electrical stimulation |
Families Citing this family (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6120502A (en) | 1988-06-13 | 2000-09-19 | Michelson; Gary Karlin | Apparatus and method for the delivery of electrical current for interbody spinal arthrodesis |
US5738521A (en) * | 1996-07-19 | 1998-04-14 | Biolectron, Inc. | Method for accelerating osseointegration of metal bone implants using electrical stimulation |
US5843185A (en) * | 1996-10-23 | 1998-12-01 | Leon Rolden; Carlos R. | Keratoprosthesis and method of corneal replacement |
US6214049B1 (en) | 1999-01-14 | 2001-04-10 | Comfort Biomedical, Inc. | Method and apparatus for augmentating osteointegration of prosthetic implant devices |
US7713297B2 (en) * | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
SE9804536D0 (en) * | 1998-12-23 | 1998-12-23 | A & Science Invest Ab | Biological implant and method of production thereof |
US6143035A (en) * | 1999-01-28 | 2000-11-07 | Depuy Orthopaedics, Inc. | Implanted bone stimulator and prosthesis system and method of enhancing bone growth |
US7192445B2 (en) * | 2000-12-06 | 2007-03-20 | Astra Tech Ab | Medical prosthetic devices and implants having improved biocompatibility |
FR2819395B1 (en) * | 2001-01-12 | 2003-08-15 | Natural Implant Sa | TRANSIENT DENTAL IMPLANT FOR PREPARING A CELL |
WO2003002243A2 (en) | 2001-06-27 | 2003-01-09 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US6610096B2 (en) * | 2001-08-22 | 2003-08-26 | Macdonald Stuart G. | Prosthetic implants having enhanced utility |
US6916177B2 (en) * | 2002-10-24 | 2005-07-12 | Jiin-Huey Chern Lin | Dental implant with hardened calcium phosphate cement inside |
KR100487119B1 (en) * | 2002-11-26 | 2005-05-03 | 설영택 | Osseoinductive magnesium-titanate implant and method of manufacturing the same |
IL154184A0 (en) * | 2003-01-29 | 2003-07-31 | Univ Ramot | Self powered osteogenesis and osseointegration promotion and maintenance device for endesseous implants |
US8684734B1 (en) * | 2003-02-27 | 2014-04-01 | Philip Scott Lyren | Dental implant with porous body |
US7291012B2 (en) * | 2003-02-27 | 2007-11-06 | Lyren Philip S | Dental implant with porous body |
ES2569853T3 (en) | 2003-06-25 | 2016-05-12 | Biedermann Technologies Gmbh & Co. Kg | Tissue integration design for fixing implants without welding |
JP4732368B2 (en) * | 2004-02-20 | 2011-07-27 | ウッドウェルディング・アクチェンゲゼルシャフト | Implant transplanted into bone tissue, its production method and transplantation method |
BRPI0411404A (en) * | 2004-03-04 | 2006-07-25 | Young-Taek Sul | osseoinductive magnesium titanate implant and manufacturing process |
DE102004024473B4 (en) * | 2004-05-14 | 2010-06-17 | Neue Magnetodyn Gmbh | Hüftkopfkappenimplantat with device for electrical tissue stimulation |
US7758892B1 (en) * | 2004-05-20 | 2010-07-20 | Boston Scientific Scimed, Inc. | Medical devices having multiple layers |
US20060004431A1 (en) * | 2004-07-01 | 2006-01-05 | Fuller Thomas A | Prophylactic bactericidal implant |
KR100662341B1 (en) * | 2004-07-09 | 2007-01-02 | 엘지전자 주식회사 | Display apparatus and method for reappearancing color thereof |
US20060089709A1 (en) * | 2004-10-21 | 2006-04-27 | Helmus Michael N | Medical implant with average surface charge density |
WO2006052765A2 (en) * | 2004-11-04 | 2006-05-18 | Smith & Nephew, Inc. | Cycle and load measurement device |
US20060127443A1 (en) * | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery |
WO2006084239A2 (en) * | 2005-02-04 | 2006-08-10 | Intellistem Orthopaedic Innovations, Inc. | Implanted prosthetic device |
US20070038176A1 (en) * | 2005-07-05 | 2007-02-15 | Jan Weber | Medical devices with machined layers for controlled communications with underlying regions |
CN103637840A (en) * | 2005-08-23 | 2014-03-19 | 史密夫和内修有限公司 | Telemetric orthopaedic implant |
US8840660B2 (en) * | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) * | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
CA2536223A1 (en) * | 2006-02-14 | 2007-08-14 | David Charles Schlueter | Apparatus and method for cleaning the interior of transport truck trailers |
WO2007103276A2 (en) * | 2006-03-03 | 2007-09-13 | Smith & Nephew, Inc. | Systems and methods for delivering a medicament |
US20070224244A1 (en) * | 2006-03-22 | 2007-09-27 | Jan Weber | Corrosion resistant coatings for biodegradable metallic implants |
US20070224235A1 (en) * | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8048150B2 (en) * | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US20070264303A1 (en) * | 2006-05-12 | 2007-11-15 | Liliana Atanasoska | Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent |
CA3068216C (en) * | 2006-06-22 | 2023-03-07 | Board Of Regents Of The University Of Nebraska | Magnetically coupleable robotic devices and related methods |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
WO2008002778A2 (en) * | 2006-06-29 | 2008-01-03 | Boston Scientific Limited | Medical devices with selective coating |
WO2008017028A2 (en) | 2006-08-02 | 2008-02-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
WO2008033711A2 (en) | 2006-09-14 | 2008-03-20 | Boston Scientific Limited | Medical devices with drug-eluting coating |
ES2368125T3 (en) | 2006-09-15 | 2011-11-14 | Boston Scientific Scimed, Inc. | BIOEROSIONABLE ENDOPROOTHESIS WITH BIOESTABLE INORGANIC LAYERS. |
US8057534B2 (en) * | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
JP2010503489A (en) * | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Biodegradable endoprosthesis and method for producing the same |
JP2010503485A (en) * | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Medical device and method for manufacturing the same |
CA2663762A1 (en) * | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Endoprostheses |
WO2008036457A2 (en) * | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Controlling biodegradation of a medical instrument |
EP2084310A1 (en) * | 2006-10-05 | 2009-08-05 | Boston Scientific Limited | Polymer-free coatings for medical devices formed by plasma electrolytic deposition |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
EP2277563B1 (en) * | 2006-12-28 | 2014-06-25 | Boston Scientific Limited | Bioerodible endoprostheses and method of making the same |
US8609036B2 (en) | 2006-12-28 | 2013-12-17 | Agentumcidalelectrics, Inc. | Ex vivo antimicrobial devices and methods |
WO2008103181A1 (en) * | 2007-02-23 | 2008-08-28 | Smith & Nephew, Inc. | Processing sensed accelerometer data for determination of bone healing |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US7976915B2 (en) * | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US8002823B2 (en) * | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
JP2010533563A (en) | 2007-07-19 | 2010-10-28 | ボストン サイエンティフィック リミテッド | Endoprosthesis with adsorption inhibiting surface |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8815273B2 (en) * | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US8221822B2 (en) * | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
JP2010535541A (en) * | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | Coating for medical devices with large surface area |
JP6121088B2 (en) * | 2007-09-06 | 2017-04-26 | スミス アンド ネフュー インコーポレイテッド | System and method for communicating with a telemetric implant |
US8052745B2 (en) * | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20090118809A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Endoprosthesis with porous reservoir and non-polymer diffusion layer |
US8029554B2 (en) * | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US20090118813A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Nano-patterned implant surfaces |
US20090143855A1 (en) * | 2007-11-29 | 2009-06-04 | Boston Scientific Scimed, Inc. | Medical Device Including Drug-Loaded Fibers |
WO2009079389A2 (en) * | 2007-12-14 | 2009-06-25 | Boston Scientific Limited | Drug-eluting endoprosthesis |
JP5581311B2 (en) | 2008-04-22 | 2014-08-27 | ボストン サイエンティフィック サイムド,インコーポレイテッド | MEDICAL DEVICE HAVING INORGANIC MATERIAL COATING AND MANUFACTURING METHOD THEREOF |
WO2009132176A2 (en) | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) * | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
WO2009155328A2 (en) | 2008-06-18 | 2009-12-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20100004733A1 (en) * | 2008-07-02 | 2010-01-07 | Boston Scientific Scimed, Inc. | Implants Including Fractal Structures |
US7985252B2 (en) * | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) * | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
RU2545424C2 (en) | 2008-10-15 | 2015-03-27 | Смит Энд Нефью, Инк. | Composite inner retainer |
US8231980B2 (en) * | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
DE102008054920A1 (en) * | 2008-12-18 | 2010-07-01 | Biotronik Vi Patent Ag | Implant and method for producing a layer structure |
US8277458B2 (en) * | 2009-01-23 | 2012-10-02 | Biomet Sports Medicine, Llc | Apparatus and method for arthroscopic transhumeral rotator cuff repair |
US8267992B2 (en) * | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) * | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US20100274352A1 (en) * | 2009-04-24 | 2010-10-28 | Boston Scientific Scrimed, Inc. | Endoprosthesis with Selective Drug Coatings |
US8287937B2 (en) * | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US8738144B2 (en) * | 2009-05-12 | 2014-05-27 | Ingenium, Llc | Bioelectric implant and method |
US8932055B2 (en) * | 2009-06-11 | 2015-01-13 | Roberto Armanino | Method employing electric fields to selectively kill microbes in a root canal preparation |
US20110022158A1 (en) * | 2009-07-22 | 2011-01-27 | Boston Scientific Scimed, Inc. | Bioerodible Medical Implants |
US9821094B2 (en) | 2014-06-11 | 2017-11-21 | Silver Bullet Therapeutics, Inc. | Coatings for the controllable release of antimicrobial metal ions |
US8221396B2 (en) | 2009-08-27 | 2012-07-17 | Silver Bullet Therapeutics, Inc. | Bone implants for the treatment of infection |
US10265435B2 (en) | 2009-08-27 | 2019-04-23 | Silver Bullet Therapeutics, Inc. | Bone implant and systems and coatings for the controllable release of antimicrobial metal ions |
WO2011119573A1 (en) * | 2010-03-23 | 2011-09-29 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
WO2012064402A1 (en) * | 2010-11-12 | 2012-05-18 | Silver Bullet Therapeutics, Inc. | Bone implant and systems that controllably releases silver |
EP2468216B1 (en) * | 2010-12-23 | 2014-05-14 | Baumgart, Rainer, Dipl.-Ing. Dr. med. | Implantable prosthesis for replacing human hip or knee joints and the adjoining bone sections |
US8679189B1 (en) * | 2013-02-11 | 2014-03-25 | Amendia Inc. | Bone growth enhancing implant |
US10838406B2 (en) | 2013-02-11 | 2020-11-17 | The Aerospace Corporation | Systems and methods for the patterning of material substrates |
US9452242B2 (en) | 2014-06-11 | 2016-09-27 | Silver Bullet Therapeutics, Inc. | Enhancement of antimicrobial silver, silver coatings, or silver platings |
WO2016172026A1 (en) | 2015-04-20 | 2016-10-27 | The Board Of Regents Of The University Of Texas System | Clec11a is a bone growth agent |
US10639167B2 (en) * | 2015-07-06 | 2020-05-05 | Warsaw Orthopedic, Inc. | Electrically stimulated bone grafting spinal implant system and method |
US10123882B2 (en) | 2015-07-06 | 2018-11-13 | Warsaw Orthopedic, Inc. | Spinal implant system and method |
US10563069B2 (en) * | 2017-03-30 | 2020-02-18 | International Business Machines Corporation | Prevention of biofilm formation |
US11915089B2 (en) | 2021-07-09 | 2024-02-27 | Warsaw Orthopedic, Inc. | Faraday cage for digital set screw probe reader |
WO2023096857A1 (en) * | 2021-11-26 | 2023-06-01 | Ossur Iceland Ehf | Prosthetic device having a sacrificial anode |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1332295A (en) * | 1969-10-20 | 1973-10-03 | Nat Res Dev | Electrochemical cells |
US3842841A (en) * | 1971-10-29 | 1974-10-22 | Us Navy | Constant current power pack for bone healing and method of use |
US4027392A (en) * | 1976-05-10 | 1977-06-07 | Interface Biomedical Laboratories Corporation | Endosteal bionic tooth and implantation method |
US4175565A (en) * | 1977-06-22 | 1979-11-27 | Oratronics, Inc. | Method and apparatus for stimulating osteogenic activity in bone structure adjacent a dental implant |
JPS56102239A (en) * | 1980-01-21 | 1981-08-15 | Shinetsu Chem Ind Co | Member for replacing live body prosthetics |
US4506674A (en) * | 1981-11-10 | 1985-03-26 | Trustees Of The University Of Pennsylvania | Method of stimulating osteogenesis with distributed port cathode |
IT1146537B (en) * | 1981-12-17 | 1986-11-12 | Concettina Nicotra | ORAL ENDOOXY IMPLANTOLOGY DEVICE WITH BUILT-IN CURRENT GENERATOR TO FAVOR OSTEOGENESIS |
DD246028A1 (en) * | 1986-02-12 | 1987-05-27 | Karl Marx Stadt Tech Hochschul | CERAMIZED METAL IMPLANT |
US5205921A (en) * | 1991-02-04 | 1993-04-27 | Queen's University At Kingston | Method for depositing bioactive coatings on conductive substrates |
US5258044A (en) * | 1992-01-30 | 1993-11-02 | Etex Corporation | Electrophoretic deposition of calcium phosphate material on implants |
-
1992
- 1992-07-22 CA CA002074318A patent/CA2074318A1/en not_active Abandoned
-
1993
- 1993-09-28 US US08/127,491 patent/US5383935A/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112040893A (en) * | 2018-04-10 | 2020-12-04 | 德普伊新特斯产品公司 | Bipolar bone anchor with connector for electrical stimulation |
Also Published As
Publication number | Publication date |
---|---|
US5383935A (en) | 1995-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5383935A (en) | Prosthetic implant with self-generated current for early fixation in skeletal bone | |
Geesink et al. | Bonding of bone to apatite-coated implants | |
Geesink et al. | Chemical implant fixation using hydroxyl-apatite coatings | |
US5947893A (en) | Method of making a porous prothesis with biodegradable coatings | |
EP0176711B1 (en) | Implant with resorbable stem | |
Jarcho | Biomaterial aspects of calcium phosphates: properties and applications | |
Overgaard et al. | Resorption of hydroxyapatite and fluorapatite ceramic coatings on weight‐bearing implants: A quantitative and morphological study in dogs | |
US6749639B2 (en) | Coated prosthetic implant | |
EP2055267B1 (en) | Radiolucent bone graft | |
CA2191345C (en) | Apparatus and method, delivery of electrical current | |
RU2536293C2 (en) | Implant with antimicrobial coating | |
SK144593A3 (en) | Concave endoprosthesis with filling supportive for the growth of the bones | |
KR20100057796A (en) | A bone tissue implant comprising strontium ions | |
CA2358966A1 (en) | Direct current stimulation of spinal interbody fixation device | |
Hägi et al. | Mechanical insertion properties of calcium‐phosphate implant coatings | |
CN105671612A (en) | Porous metal implant with micro-arc oxidation coating and preparation method | |
Spector et al. | Porous polysulfone coatings for fixation of femoral stems by bony ingrowth. | |
AU757889B2 (en) | Bone implant | |
Driskell¹ | Early history of calcium phosphate materials and coatings | |
Salman et al. | The effect of direct electrical current stimulation on the bone/porous metallic implant interface | |
CN201529174U (en) | Biological type composite femoral stem | |
Blom et al. | Cortical bone ingrowth in growth hormone-loaded grooved implants with calcium phosphate coatings in goat femurs | |
CN1266670A (en) | Biologically compounded artificial hollow joint | |
Jasty et al. | Bone ingrowth into a low-modulus composite plastic porous-coated canine femoral component | |
Reikeras et al. | Bone ingrowths to press-fit and loose-fit implants: Comparisons between titanium and hydroxyapatite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |